Kathleen P. Mullinix
Keine laufenden Positionen mehr
Profil
Kathleen P.
Mullinix served as Chairman, President & CEO at Lundbeck Research USA, Inc. from 1987 to 2002.
She was also the CEO of WellGen, Inc. and a Director at Intellect Neurosciences, Inc. and The Jackson Laboratory.
Additionally, she served as an Independent Director at Lixte Biotechnology Holdings, Inc. in 2012.
Mullinix holds a doctorate from The Trustees of Columbia University in The City of New York and an undergraduate degree from Trinity College (Connecticut).
Ehemalige bekannte Positionen von Kathleen P. Mullinix
| Unternehmen | Position | Ende |
|---|---|---|
| LIXTE BIOTECHNOLOGY HOLDINGS, INC. | Direktor/Vorstandsmitglied | 22.11.2012 |
| INTELLECT NEUROSCIENCES, INC. | Direktor/Vorstandsmitglied | 22.01.2010 |
WellGen, Inc.
 WellGen, Inc. Pharmaceuticals: MajorHealth Technology WellGen, Inc. develops products for inflammation-based diseases. The company was founded in 1997 and is headquartered in New York, NY. | Präsident | 22.08.2008 |
Lundbeck Research USA, Inc.
 Lundbeck Research USA, Inc. Pharmaceuticals: MajorHealth Technology Lundbeck Research USA, Inc. develops pharmaceutical products and information to the medical community. The firm engages in the drug discovery aimed at treating central nervous system diseases by designing small molecule therapeutics. The company was founded in 1990 and is headquartered in Paramus, NJ. | Vorsitzender | 01.12.2002 |
The Jackson Laboratory
 The Jackson Laboratory BiotechnologyHealth Technology The Jackson Laboratory provides biotechnology research services. It offers nonprofit research, biomedical research, genomics, genetics, cancer, neuroscience, immunology, aging, bioinformatics, computational biology, research mice, genomic medicine, reproductive biology, developmental biology, eye research and hearing research. The company was founded by Clarence Cook Little in 1929 and is headquartered in Bar Harbor, ME. | Direktor/Vorstandsmitglied | - |
Ausbildung von Kathleen P. Mullinix
| Trinity College (Connecticut) | Undergraduate Degree |
| The Trustees of Columbia University in The City of New York | Doctorate Degree |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Börsennotierte Unternehmen | 1 |
|---|---|
| LIXTE BIOTECHNOLOGY HOLDINGS, INC. | Health Technology |
| Private Unternehmen | 4 |
|---|---|
WellGen, Inc.
WellGen, Inc. Pharmaceuticals: MajorHealth Technology WellGen, Inc. develops products for inflammation-based diseases. The company was founded in 1997 and is headquartered in New York, NY. | Health Technology |
Intellect Neurosciences, Inc.
 Intellect Neurosciences, Inc. Pharmaceuticals: MajorHealth Technology Intellect Neurosciences, Inc. is a biopharmaceutical company, which engages in the discovery and development of disease-modifying therapeutic agents. It specializes in treatment and prevention of neurodegenerative conditions, collectively known as proteinopathies, which include alzheimer's, parkinson's and huntington disease. The company was founded by Daniel G. Chain on April 25, 2005 and is headquartered in Englewood Cliffs, NJ. | Health Technology |
The Jackson Laboratory
The Jackson Laboratory BiotechnologyHealth Technology The Jackson Laboratory provides biotechnology research services. It offers nonprofit research, biomedical research, genomics, genetics, cancer, neuroscience, immunology, aging, bioinformatics, computational biology, research mice, genomic medicine, reproductive biology, developmental biology, eye research and hearing research. The company was founded by Clarence Cook Little in 1929 and is headquartered in Bar Harbor, ME. | Health Technology |
Lundbeck Research USA, Inc.
Lundbeck Research USA, Inc. Pharmaceuticals: MajorHealth Technology Lundbeck Research USA, Inc. develops pharmaceutical products and information to the medical community. The firm engages in the drug discovery aimed at treating central nervous system diseases by designing small molecule therapeutics. The company was founded in 1990 and is headquartered in Paramus, NJ. | Health Technology |
